Amedisys EBIT

Amedisys (AMED) currently reports a EBIT of $120M as of June 2025. That compares with $180M in the prior-year period — down 32.3% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Amedisys's EBIT history and peer comparisons.

Amedisys's EBIT decreased from $180M to $120M — a 32.3% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amedisys's EBIT of $120M is lower than the Healthcare sector average of $23B. That is roughly 99.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Amedisys reported $120M in EBIT as of June 2025. That compares with $180M in the prior-year period — down 32.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Amedisys, and consider following AMED for alerts when major investors trade the stock.